[Amitriptyline in the treatment of anxiety and insomnia anal as a tranquilizer].
Thirty out patients were selected in a psychiatric hospital among those presenting insomnia, anxiety, psychomotor retardation, loss of drive and anxiety with somatic manifestations. Amytryptyline was administered in 25 mg tablets, one to four times a day, for twelve weeks. Results were satisfactory as observed from the second week; side effects were minimal. We can conclude that amytryptyline is of great effectiveness in the treatment of the neurotic illnesses most commonly observed in clinical practice.
D000293:Adolescent; D000328:Adult; D000639:Amitriptyline / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D014149:Tranquilizing Agents; D000639:Amitriptyline
La amitriptilina en el tratamiento de la ansiedad y el insomnnio, y como tranquilizante